NEW RAY MED-10K 06108·

Gross margin --------------------------------------------------------8.49%--14.76%6.26%25.80%11.04%12.23%13.57%12.39%0.15% Net margin ---------------------------------------------------------0.84%---86.83%85.99%-44.20%42.62%-33.01%11.19%-15.39%17.62% ROE ---------------------------------------------------------0.45%---14.83%14.38%-4.62%10.21%-6.59%1.97%-4.73%1.85% ROA ---------------------------------------------------------0.43%---14.44%14.01%-4.51%9.93%-6.14%1.63%-4.60%1.54% Revenue growth -------------------------------------------------------------70.76%---43.32%27.43%91.41%134.73%35.36%56.05% Attributable profit growth -------------------------------------------------------------2915.62%--71.15%2986.77%-42.95%114.09%36.89%79.84% Debt-to-assets --------------------------------------------------------4.45%--2.63%1.82%2.31%0.32%6.78%4.48%2.82%3.97% Current ratio --------------------------------------------------------24.83--51.4726.6468.0816.6112.0156.0855.9443.93 Operating cash flow / net profit --------------------------------------------------------20.68--0.0020.672.052.040.151.892.702.54 Operating cash flow / revenue ---------------------------------------------------------17.41%---0.35%17.06%-90.54%90.18%-5.07%85.46%-41.53%36.46%

Gross margin 8.13%--8.68%0.55% Net margin -16.68%---3.14%13.53% Revenue growth ----153.73%-- Attributable profit growth ----52.17%-- Debt-to-assets ----7.48%-- Current ratio ----11.65--

Revenue --------------------------------------------------------274.21M--80.19M70.76%45.45M43.32%87.00M91.41%117.76M35.36% Other income and gains --------------------------------------------------------2.16M---5.98M376.82%-1.19M80.15%1.90M260.07%615.09K67.63% Gross profit --------------------------------------------------------23.29M--11.83M49.19%11.73M0.90%10.64M9.25%14.59M37.06% Selling and distribution expenses --------------------------------------------------------10.33M--17.19M66.44%12.75M25.84%14.70M15.34%8.24M43.93% Administrative expenses --------------------------------------------------------14.95M--18.19M21.68%13.26M27.12%13.64M2.85%13.94M2.27% Net finance costs --------------------------------------------------------228.93K--158.11K30.94%29.00K81.66%94.46K225.72%129.16K36.74% Income tax --------------------------------------------------------641.00K--2.09M225.95%155.87K92.54%969.56K522.03%112.90K88.36% Operating profit ---------------------------------------------------------3.63M---71.56M1872.13%-20.22M71.75%-29.59M46.38%-17.88M39.57% Share of associates and JVs --------------------------------------------------------907.54K------------------ Profit before tax ---------------------------------------------------------2.95M---71.72M2331.17%-20.25M71.77%-29.69M46.63%-18.01M39.33% Net profit ---------------------------------------------------------2.31M---69.63M2915.62%-20.09M71.15%-28.72M42.95%-18.12M36.89% Net profit attributable to owners ---------------------------------------------------------2.31M---69.63M2915.62%-20.09M71.15%-28.72M42.95%-18.12M36.89%

Revenue 44.70M--113.42M153.73% Other income and gains -709.00K---1.55M118.76% Cost of sales 41.06M--103.58M152.22% Gross profit 3.64M--9.84M170.74% Selling and distribution expenses 4.98M--6.32M26.98% Administrative expenses 6.00M--6.85M14.16% Net finance costs 83.00K--73.00K12.05% Income tax 0--0-- Profit before tax -7.45M---3.56M52.17% Net profit -7.45M---3.56M52.17% Net profit attributable to owners -7.45M---3.56M52.17%

Cash and cash equivalents ----------------------------------------------------------------94.21M--59.50M36.84%26.57M55.35% Trade and bills receivables --------------------------------------------------------167.33M--188.16M12.45%217.69M15.69%223.60M2.71%234.04M4.67% Inventories --------------------------------------------------------102.45M--31.47M69.28%28.24M10.25%18.62M34.09%21.10M13.36% Total current assets --------------------------------------------------------395.75M--360.76M8.84%342.73M5.00%303.67M11.40%293.20M3.45% Total assets --------------------------------------------------------541.29M--482.23M10.91%445.50M7.62%467.87M5.02%394.26M15.73% Total current liabilities --------------------------------------------------------15.94M--7.01M56.02%5.03M28.18%25.29M402.42%5.24M79.28% Total liabilities --------------------------------------------------------24.10M--12.68M47.39%10.29M18.87%31.74M208.62%11.10M65.03% Equity attributable to owners --------------------------------------------------------517.19M--469.55M9.21%435.21M7.31%436.12M0.21%383.16M12.14% Total equity --------------------------------------------------------517.19M--469.55M9.21%435.21M7.31%436.12M0.21%383.16M12.14%

Cash and cash equivalents ----73.58M-- Trade and bills receivables ----248.75M-- Inventories ----21.80M-- Total current assets ----344.14M-- Total assets ----471.07M-- Total current liabilities ----29.55M-- Total liabilities ----35.23M-- Equity attributable to owners ----435.85M-- Total equity ----435.85M--

Net cash from operating activities ---------------------------------------------------------47.74M---284.06K99.40%-41.15M14385.94%-4.41M89.27%-48.90M1008.01% Net cash from investing activities --------------------------------------------------------107.19M--1.45M98.65%-5.45M477.02%-28.62M425.16%7.23M125.27% Net cash from financing activities --------------------------------------------------------8.27M---11.19M235.30%-918.00K91.79%-1.46M59.48%5.52M477.13% Net change in cash --------------------------------------------------------67.72M---10.03M114.80%-47.52M373.92%-34.49M27.41%-36.15M4.80%